Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
8.75
+0.63 (7.76%)
At close: Apr 28, 2026, 4:00 PM EDT
8.80
+0.05 (0.57%)
Pre-market: Apr 29, 2026, 8:40 AM EDT
Sagimet Biosciences Employees
Sagimet Biosciences had 16 employees as of December 31, 2025. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$3,189,875
Market Cap
285.12M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16 | 2 | 14.29% |
| Dec 31, 2024 | 14 | 4 | 40.00% |
| Dec 31, 2023 | 10 | 0 | - |
| Dec 31, 2022 | 10 | 3 | 42.86% |
| Dec 31, 2020 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MacroGenics | 293 |
| Karyopharm Therapeutics | 228 |
| Tonix Pharmaceuticals Holding | 142 |
| Cartesian Therapeutics | 75 |
| Precision BioSciences | 68 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 58 |
SGMT News
- 1 day ago - Why Is Sagimet Biosciences Stock Trading Higher On Monday? - Benzinga
- 2 days ago - Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock - GlobeNewsWire
- 2 days ago - Sagimet Biosciences Provides Strategic and Corporate Updates - GlobeNewsWire
- 9 days ago - Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer - GlobeNewsWire
- 23 days ago - Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 7 weeks ago - Sagimet Biosciences Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Sagimet Biosciences Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts